Correlation Between Curative Biotechnology and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Curative Biotechnology and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Curative Biotechnology and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Curative Biotechnology and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Curative Biotechnology and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Curative Biotechnology with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Curative Biotechnology and Regeneron Pharmaceuticals.
Diversification Opportunities for Curative Biotechnology and Regeneron Pharmaceuticals
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Curative and Regeneron is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Curative Biotechnology and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Curative Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Curative Biotechnology are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Curative Biotechnology i.e., Curative Biotechnology and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Curative Biotechnology and Regeneron Pharmaceuticals
Given the investment horizon of 90 days Curative Biotechnology is expected to generate 5.67 times more return on investment than Regeneron Pharmaceuticals. However, Curative Biotechnology is 5.67 times more volatile than Regeneron Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 1.18 in Curative Biotechnology on November 9, 2024 and sell it today you would earn a total of 0.07 from holding Curative Biotechnology or generate 5.93% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Curative Biotechnology vs. Regeneron Pharmaceuticals
Performance |
Timeline |
Curative Biotechnology |
Regeneron Pharmaceuticals |
Curative Biotechnology and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Curative Biotechnology and Regeneron Pharmaceuticals
The main advantage of trading using opposite Curative Biotechnology and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Curative Biotechnology position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.Curative Biotechnology vs. Biotron Limited | Curative Biotechnology vs. biOasis Technologies | Curative Biotechnology vs. Covalon Technologies | Curative Biotechnology vs. Mosaic Immunoengineering |
Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |